In a regulatory filing on Friday, Tempus AI (TEM) disclosed that Chairman and CEO Eric Lefkofsky sold a series of shares beginning on January ...

Shares of Tempus AI (TEM) are down 92c, or 2%, to $49.53 in Thursday morning trading after it was disclosed in a regulatory filing last night that founder and CEO Eric Lefkofsky disposed of ...

To learn more about olivia and how it can support your health journey, visit oliviahealth.ai. About Tempus Tempus is a technology company advancing precision medicine through the practical ...

CHICAGO, January 21, 2025--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ ... olivia is an AI-enabled personal health concierge app designed to empower patients by bringing their health-related data ...

In other recent news, Tempus AI announced the national launch of its AI-enabled personal health concierge app, Olivia. The company also reported preliminary fourth-quarter 2024 total revenues of ...

Coming to the latest development around Olivia, the investors are optimistic, evident from the stock surge last week.

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced the national launch of olivia. olivia is an AI-enabled ...

Additionally, olivia connects to external resources, such as clinicaltrials.gov, to supplement the personalized insights offered from existing health data. “At Tempus, our goal has always been ...

Alignment Healthcare and Clover Health. Precision medicine company Tempus AI, which uses artificial intelligence to process medical data, announced this week new capabilities within its generative ...